exenatide-XTEN (VRS-859)
/ Aravive
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 22, 2010
Versartis initiates first clinical trial for new diabetes drug VRS-859 (exenatide-XTEN)
(PipelineReview)
-
Dosing of patients started in P1a trial; P1b study planned to begin in Q4 ’10;
P1 initiation • Diabetes
1 to 1
Of
1
Go to page
1